Enabling
Japanese Innovation
to Scale Through
the NANO Bridge

Nano Bridge Investment unlocks the intrinsic value
of Japan’s high-potential technologies through strategic capital
and hands-on business support, helping companies grow globally
and enhance enterprise value.

scroll down

ABOUT US

Unlocking Growth Opportunities
for Exceptional Japanese Technologies

Japan is home to many companies with world-class technologies, yet their true value is not always fully recognized in the capital markets.

Nano Bridge Investment supports these companies by providing strategic capital, capital strategy, and business development support to enhance enterprise value and accelerate global growth.

ABOUT US

our business

our business

Investment Across Four Strategic Areas

Nano Bridge Investment invests across four strategic areas:

our business our business

By integrating capital strategy with management support, we provide end-to-end support from investment to growth acceleration.

fund over view

fund over view

NBI-SBISGC No. 1 Investment Limited Partnership BioBridge I

■ Nano Bridge Investment manages BioBridge I, an investment fund focused primarily on healthcare and biotechnology.
The fund provides strategic capital and hands-on management support to Japanese companies with high-potential technologies, leveraging sector expertise and domestic and international networks to drive enterprise value and global expansion.
Fund Name
NBI-SBISGC 1 Investment Limited Partnership
(BioBridge I)
Fund Size
JPY 10–15 billion
Formation Date
January 30, 2026
Fund Term
January 30, 2026 – December 31, 2032
Target IRR
25%
General Partners (GP)
Nano Bridge Investment Co., Ltd.
SBI Shinsei Growth Capital Co., Ltd.

Major Portfolio

Portfolio Companies

NATiAS Inc.
Under Construction